Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Boulenger

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
La Nouvelle Presse Medicale|July 11, 1979
[Mechanisms of action of the benzodiazepines. New biological data]J P Boulenger
L'Encephale|November 1, 1995
[Treatment of generalized anxiety: new pharmacologic approaches]J P Boulenger
Servir (Lisbon, Portugal)|January 1, 1986
[Caffeine, stress and anxiety]J P Boulenger
La Nouvelle Presse Medicale|May 13, 1982
[Clinical evaluation of new anxiolytic drugs (author's transl)]J P Boulenger
L'Encephale|September 26, 2008
[From one indication to another: the benefit of longitudinal studies]J P Boulenger
L'Encephale|January 1, 1976
[Mechanism of action of lithium in manic-depressive psychoses: current research results]J P Boulenger, S Brion
L'Encephale|January 1, 1981
[Neuroleptic-tricyclic antidepressant combination. Pharmacological aspects and therapeutic interest (author's transl)]J P Boulenger, E Zarifian
Revue D'Epidemiologie Et De Sante Publique|January 1, 1985
[Peripheral biological markers in psychiatry: value of epidemiologic studies?]J P Boulenger, E Zarifian
L'Encephale|September 1, 1991
[Beta-blocking drugs and anxiety. A proven therapeutic value]B Laverdure, J P Boulenger
L'Encephale|April 26, 2007
[Pharmacological treatment of generalized anxiety disorders: rationale and limitations]J-P Boulenger, D Capdevielle
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
La Nouvelle Presse Medicale|July 11, 1979
[Mechanisms of action of the benzodiazepines. New biological data]J P Boulenger
L'Encephale|November 1, 1995
[Treatment of generalized anxiety: new pharmacologic approaches]J P Boulenger
Servir (Lisbon, Portugal)|January 1, 1986
[Caffeine, stress and anxiety]J P Boulenger
La Nouvelle Presse Medicale|May 13, 1982
[Clinical evaluation of new anxiolytic drugs (author's transl)]J P Boulenger
L'Encephale|September 26, 2008
[From one indication to another: the benefit of longitudinal studies]J P Boulenger
L'Encephale|January 1, 1976
[Mechanism of action of lithium in manic-depressive psychoses: current research results]J P Boulenger, S Brion
L'Encephale|January 1, 1981
[Neuroleptic-tricyclic antidepressant combination. Pharmacological aspects and therapeutic interest (author's transl)]J P Boulenger, E Zarifian
Revue D'Epidemiologie Et De Sante Publique|January 1, 1985
[Peripheral biological markers in psychiatry: value of epidemiologic studies?]J P Boulenger, E Zarifian
L'Encephale|September 1, 1991
[Beta-blocking drugs and anxiety. A proven therapeutic value]B Laverdure, J P Boulenger
L'Encephale|April 26, 2007
[Pharmacological treatment of generalized anxiety disorders: rationale and limitations]J-P Boulenger, D Capdevielle
Pageof 10